Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring <i>RET</i> Gene Alterations

Michael V. Ortiz, Ulrike Gerdemann, Sandya Govinda Raju, Dahlia Henry, Steve Smith, S. Michael Rothenberg, Michael C. Cox, Stéphanie Proust, Julia Glade Bender, A. Lindsay Frazier, Peter M. Anderson, Alberto S. Pappo